HB 1102-1_ Filed 01/25/2011, 11:02 Dvorak


Text Box


    PREVAILED      Roll Call No. _______
    FAILED        Ayes _______
    WITHDRAWN        Noes _______
    RULED OUT OF ORDER


[

HOUSE MOTION ____

]

MR. SPEAKER:

    I move that House Bill 1102 be amended to read as follows:

SOURCE: Page 1, line 14; (11)MO110201.1. -->     Page 1, line 14, delete "salvia divinorum," and insert " or salvia divinorum".
    Page 1, line 15, delete "or a synthetic cannabinoid".
    Page 5, line 11, after "hashish," insert " or".
    Page 5, line 12, delete ", or a synthetic cannabinoid".
    Page 7, line 3, delete "salvia divinorum," and insert " or salvia divinorum".
    Page 7, line 4, delete "or a synthetic cannabinoid".
    Page 8, line 23, delete "salvia divinorum," and insert " or salvia divinorum".
    Page 8, line 24, delete "or a synthetic cannabinoid".
    Page 11, line 28, after "hashish," insert " or".
    Page 11, line 29, delete ", or a synthetic cannabinoid".
    Page 12, line 18, delete "salvia divinorum," and insert " or salvia divinorum".
    Page 12, line 19, delete "or a synthetic cannabinoid".
    Page 14, line 15, after "hashish," insert " or".
    Page 14, line 16, delete ", or a synthetic cannabinoid".
    Page 15, line 9, delete "salvia divinorum," and insert " or salvia divinorum".
    Page 15, line 10, delete "or a synthetic cannabinoid".
    Page 16, line 2, after "hashish," insert " or".
    Page 16, line 3, delete ", or a synthetic cannabinoid".
    Page 17, line 3, after "hashish," insert " or".
    Page 17, line 4, delete ", or a synthetic cannabinoid".
    Page 19, line 14, after "hashish," insert " or".
    Page 19, line 15, delete ", or a synthetic cannabinoid)" and insert " )".
    Page 19, delete lines 24 through 42.
    Page 20, delete lines 1 through 18.
    Page 21, line 39, delete "salvia divinorum," and insert " or salvia divinorum".
    Page 21, line 40, delete "or a synthetic cannabinoid".
    Page 22, between lines 5 and 6, begin a new paragraph and insert:
SOURCE: IC 35-48-2-4; (11)MO110201.10. -->     "SECTION 10. IC 35-48-2-4, AS AMENDED BY P.L.22-2008, SECTION 1, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE JULY 1, 2011]: Sec. 4. (a) The controlled substances listed in this section are included in schedule I.
    (b) Opiates. Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted by rule of the board or unless listed in another schedule, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation:
        Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4- piperidinyl]-N-phenylacetamide) (9815)
        Acetylmethadol (9601)
        Allylprodine (9602)
        Alpha-methylthiofentanyl (N-[1-methyl-2-(2- thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) (9832)
        Alphacetylmethadol (9603)
        Alphameprodine (9604)
        Alphamethadol (9605)
        Alphamethylfentanyl (9814)
        Benzethidine (9606)
        Beta-hydroxy-3-methylfentanyl (9831). Other name: N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl
        ]-N-phenylpropanamide
        Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2- phenethyl)-4-piperidinyl]-N-phenylpropanamide) (9830)
        Betacetylmethadol (9607)
        Betameprodine (9608)
        Betamethadol (9609)
        Betaprodine (9611)
        Clonitazene (9612)
        Dextromoramide (9613)
        Diampromide (9615)
        Diethylthiambutene (9616)
        Difenoxin (9168)
        Dimenoxadol (9617)
        Dimepheptanol (9618)
        Dimethylthiambutene (9619)
        Dioxaphetyl butyrate (9621)
        Dipipanone (9622)
        Ethylmethylthiambutene (9623)
        Etonitazene (9624)
        Etoxeridine (9625)
        Furethidine (9626)
        Hydroxypethidine (9627)
        Ketobemidone (9628)
        Levomoramide (9629)
        Levophenacylmorphan (9631)
        3-Methylfentanyl [N-[3-methyl-1-(2-phenylethyl)-4-
        piperidyl]-N-phenyl-propanimide](9813)
        3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4- piperidinyl]-N-phenylpropanamide) (9833)
        MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) (9961)
        Morpheridine (9632)
        N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), including any isomers, salts, or salts of isomers (9818)
        N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl), including any isomers, salts, or salts of isomers (9834)
        Noracymethadol (9633)
        Norlevorphanol (9634)
        Normethadone (9635)
        Norpipanone (9636)
        Para-fluorofentanyl (N-(4-fluorophenyl)-N- [1-(2-phenethyl)-4-piperidinyl] propanamide (9812)
        Phenadoxone (9637)
        Phenampromide (9638)
        Phenomorphan (9647)
        Phenoperidine (9641)
        PEPAP [1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine] (9663)
        Piritramide (9642)
        Proheptazine (9643)
        Properidine (9644)
        Propiram (9649)
        Racemoramide (9645)
        Thiofentanyl (N-phenyl-N-[ 1-(2-thienyl)ethyl-4- piperidinyl]-propanamide) (9835)
        Tilidine (9750)
        Trimeperidine (9646)
    (c) Opium derivatives. Any of the following opium derivatives, their salts, isomers, and salts of isomers, unless specifically excepted by rule of the board or unless listed in another schedule, whenever the existence of these salts, isomers, and salts of isomers is possible within

the specific chemical designation:
        Acetorphine (9319)
        Acetyldihydrocodeine (9051)
        Benzylmorphine (9052)
        Codeine methylbromide (9070)
        Codeine-N-Oxide (9053)
        Cyprenorphine (9054)
        Desomorphine (9055)
        Dihydromorphine (9145)
        Drotebanol (9335)
        Etorphine (except hydrochloride salt) (9056)
        Heroin (9200)
        Hydromorphinol (9301)
        Methyldesorphine (9302)
        Methyldihydromorphine (9304)
        Morphine methylbromide (9305)
        Morphine methylsulfonate (9306)
        Morphine-N-Oxide (9307)
        Myrophine (9308)
        Nicocodeine (9309)
        Nicomorphine (9312)
        Normorphine (9313)
        Pholcodine (9314)
        Thebacon (9315)
    (d) Hallucinogenic substances. Any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic, psychedelic, or psychogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted by rule of the board or unless listed in another schedule, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
        (1) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (7473). Other name: TCPy.
        (2) 4-Bromo-2, 5-Dimethoxyamphetamine (7391). Some trade or other names: 4-Bromo-2, 5-Dimethoxy-a-methylphenethylamine; 4-Bromo-2, 5-DMA.
        (3) 4-Bromo-2, 5-dimethoxphenethylamine (7392). Some trade or other names:
        2-[4-bromo-2,5-dimethoxyphenyl]-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus.
        (4) 2, 5-Dimethoxy-4-ethylamphet-amine (7399). Other name: DOET.
        (5) 2, 5-Dimethoxy-4-(n)-propylthiophenethylamine (7348). Other name: 2C-T-7.
        (6) 2, 5-Dimethoxyamphetamine (7396). Some trade or other names: 2, 5-Dimethoxy-a-methylphenethylamine; 2, 5-DMA.


        (7) 4-Methoxyamphetamine (7411). Some trade or other names: 4-Methoxy-a-methylphenethylamine; Paramethoxyamphetamine; PMA.
        (8) 5-Methoxy-3, 4-methylenedioxy amphetamine (7401). Other Name: MMDA.
        (9) 5-Methoxy-N, N-diisopropyltryptamine, including any isomers, salts, or salts of isomers (7439). Other name: 5-MeO-DIPT.
        (10) 4-methyl-2, 5-dimethoxyamphetamine (7395). Some trade and other names: 4-methyl-2, 5-dimethoxy-a-methylphenethylamine; DOM; and STP.
        (11) 3, 4-methylenedioxy amphetamine (7400). Other name: MDA.
        (12) 3,4-methylenedioxy-N-ethylamphetamine (7404). Other names: N-ethyl-alpha-methyl-3,4(methylenedioxy) phenethylamine; N-ethyl MDA; MDE; and MDEA.
        (13) 3, 4-methylenedioxymethamphetamine (MDMA) (7405).
        (14) 3, 4, 5-trimethoxy amphetamine (7390). Other name: TMA.
        (15) Alpha-ethyltryptamine (7249). Some trade and other names: Etryptamine; Monase; [alpha]-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; [alpha]-ET; and AET.
        (16) Alpha-methyltryptamine (7432). Other name: AMT.
        (17) Bufotenine (7433). Some trade and other names: 3-(B-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminonethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N, N-dimethyltryptamine; mappine.
        (18) Diethyltryptamine (7434). Some trade or other names: N, N-Diethyltryptamine; DET.
        (19) Dimethyltrytamine (7435). Some trade or other names: DMT.
        (20) Ibogaine (7260). Some trade and other names: 7-Ethyl-6, 6b, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-pyrido (1', 2': 1, 2, azepino 4, 5-b) indole; tabernanthe iboga.
        (21) Lysergic acid diethylamide (7315). Other name: LSD.
        (22) Marijuana (7360).
        (23) Mescaline (7381).
        (24) Parahexyl (7374). Some trade or other names: 3-Hexyl-1-hydroxy-7, 8, 9, 10-Tetrahydro-6, 6, 9-trimethyl-6H-dibenzo (b,d) pyran; Snyhexyl.
        (25) Peyote (7415), including:
            (A) all parts of the plant that are classified botanically as lophophora williamsii lemaire, whether growing or not;
            (B) the seeds thereof;
            (C) any extract from any part of the plant; and
            (D) every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or extracts.
        (26) N-ethyl-3-piperidyl benzilate (7482). Other name: DMZ.
        (27) N-hydroxy-3,4-methylenedioxyamphetamine (7402). Other names: N-hydroxy-alpha-methyl-3,4 (methylenedioxy)phenethylamine; and N-hydroxy MDA.
        (28) N-methyl-3-piperidyl benzilate (7484). Other name: LBJ.
        (29) Psilocybin (7437).
        (30) Psilocyn (7438).
        (31) Tetrahydrocannabinols (7370), including synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, sp. and synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity such as any of the following:
            (A) .1 cis or trans tetrahydrocannabinol, and their optical isomers.
            (B) .6 cis or trans tetrahydrocannabinol, and their optical isomers. and
            (C) .3,4 cis or trans tetrahydrocannabinol, and their optical isomers.
             (D) JWH-015 ((2-Methyl-1-propyl-1H- indol-3-yl)-1-naphthalenylmethanone).
            (E) JWH-018 (1-pentyl-3-(1-naphthoyl)indole).
            (F) JWH-019 (1-hexyl-3-(naphthalen-1-oyl)indole).
            (G) JWH-073 (naphthalen-1-yl- (1-butylindol-3-yl)methanone).
            (H) JWH-081 (4-methoxynaphthalen- 1-yl- (1-pentylindol- 3-yl)methanone).
            (I) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
            (J) JWH-200 ((1-(2-morpholin-4-ylethyl)indol-3-yl)- naphthalen-1-ylmethanone).
            (K) JWH-250 (1-pentyl-3-(2-methoxyphenylacetyl)indole).
            (L) JWH-251 (1-pentyl-3-(2-methylphenylacetyl)indole).
            (M) JWH-398 (1-pentyl-3-(4-chloro-1-naphthoyl)indole).
            (N) HU-210 ((6aR,10aR)- 9-(Hydroxymethyl)- 6,6-dimethyl- 3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo [c]chromen- 1-ol).

             (O) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)- 6,6-dimethyl- 3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo [c]chromen-1-ol).
            (P) HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4- (2-methyloctan- 2-yl)phenyl]- 7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol).
            (Q) HU-331 (3-hydroxy-2- [(1R,6R)-3-methyl-6- (1-methylethenyl)-2 -cyclohexen-1-yl]-5 -pentyl-2,5-cyclohexadiene-1,4-dione).

             (R) CP 55,940 (2-[(1R,2R,5R)-5-hydroxy-2-(3- hydroxypropyl) cyclohexyl]- 5- (2-methyloctan-2-yl)phenol).
            (S) CP 47,497 (2-[(1R,3S)-3-hydroxycyclohexyl]- 5- (2-methyloctan-2-yl)phenol) and its homologues.
            (T) WIN 55212-2 (R)-(+)-[2,3-Dihydro-5-methyl-3- (4-morpholinylmethyl) pyrrolo [1,2,3-de]- 1,4- benzoxazin- 6-yl]-1-napthalenylmethanone).

        Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions are covered. Other name: THC.
        (32) Ethylamine analog of phencyclidine (7455). Some trade or other names: N-Ethyl-1-phenylcyclohexylamine; (1-phenylcyclohexyl) ethylamine; N-(1-phenylcyclohexyl) ethylamine; cyclohexamine; PCE.
        (33) Pyrrolidine analog of phencyclidine (7458). Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine; PCPy; PHP.
        (34) Thiophene analog of phencyclidine (7470). Some trade or other names: 1-(1-(2-thienyl) cyclohexyl) piperidine; 2-Thienyl Analog of Phencyclidine; TPCP.
    (e) Depressants. Unless specifically excepted in a rule adopted by the board or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
        Gamma-hydroxybutyric acid (other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate) (2010)
        Mecloqualone (2572)
        Methaqualone (2565)
    (f) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
        ([+/-]) cis-4-methylaminorex (([+/-])cis-4,5- dihydro-4-methyl-5-phenyl-2-oxazolamine) (1590)
        Aminorex (1585). Other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenyl-2-oxazolamine.
        Cathinone (1235). Some trade or other names: 2-amino-1-phenyl-1-propanone; alpha-aminopropiophenone; 2-aminopropiophenone; and norephedrone.
        Fenethylline (1503)
        N-Benzylpiperazine (7493). Other names: BZP; and 1-benzylpiperazine.
        N-ethylamphetamine (1475)
        Methcathinone (1237) Some other trade names: 2-Methylamino-1-Phenylpropan-I-one; Ephedrone; Monomethylpropion; UR 1431.
        N, N-dimethylamphetamine (1480). Other names: N, N-alpha-trimethyl-benzeneethanamine; and N, N-alpha-trimethylphenethylamine.".
SOURCE: Page 22, line 14; (11)MO110201.22. -->     Page 22, line 14, after "hashish," insert " or".
    Page 22, line 15, delete ", or a synthetic cannabinoid;" and insert " ;".
    Page 22, line 22, after "hashish," insert " or".
    Page 22, line 23, delete ", or a synthetic cannabinoid;" and insert " ;".
    Page 23, line 2, after "hashish," insert " or".
    Page 23, line 3, delete "or a synthetic cannabinoid,".
    Page 23, line 32, delete "a synthetic".
    Page 23, line 33, delete "cannabinoid,".
    Page 23, line 35, delete "a synthetic cannabinoid,".
    Page 23, line 40, delete "a synthetic cannabinoid,".
    Page 23, line 42, delete "a synthetic cannabinoid," .
    Page 24, line 13, delete "a synthetic".
    Page 24, line 14, delete "cannabinoid,".
    Page 24, line 16, delete "a synthetic cannabinoid,".
    Page 24, line 21, delete "a synthetic cannabinoid,".
    Page 24, line 23, delete "a synthetic cannabinoid,".
    Page 24, line 33, delete "a synthetic cannabinoid,".
    Page 25, line 7, after "hashish," insert " or".
    Page 25, line 7, delete "or a synthetic".
    Page 25, line 8, delete "cannabinoid,".
    Page 25, line 14, after "hashish," insert " or".
    Page 25, line 14, delete "or a synthetic".
    Page 25, line 15, delete "cannabinoid,".
    Page 25, line 16, after "hashish," insert " or".
    Page 25, line 17, delete "or a synthetic cannabinoid,".
    Page 25, line 26, after "hashish," insert " or".
    Page 25, line 26, delete ", or a synthetic cannabinoid;" and insert " ;".
    Page 25, line 28, after "hashish" insert " or".
    Page 25, line 28, delete ", or a" and insert " ;".
    Page 25, line 29, delete "synthetic cannabinoid;".
    Page 25, line 32, after "hashish," insert " or".
    Page 25, line 32, delete "or a synthetic cannabinoid,".
    Page 25, line 34, after "hashish," insert " or".
    Page 25, line 34, delete ", or a synthetic" and insert " :".
    Page 25, delete line 35.
    Page 26, line 3, after "hashish," insert " or".
    Page 26, line 3, delete ", or a synthetic" and insert " ;".
    Page 26, delete line 4.
    Page 26, line 8, after "hashish," insert " or".
    Page 26, line 9, delete "or a synthetic cannabinoid,".
    Page 26, line 12, after "hashish," insert " or".
    Page 26, line 12, delete "or a synthetic cannabinoid,".
    Page 26, line 14, after "hashish," insert " or".
    Page 26, line 14, delete ", or a synthetic cannabinoid." and insert " .".
    Page 26, line 19, after "hashish," insert " or".
    Page 26, line 19, delete ", or a synthetic".
    Page 26, line 20, delete "cannabinoid".
    Renumber all SECTIONS consecutively.
    (Reference is to HB 1102 as printed January 21, 2011.)

________________________________________

Representative Dvorak


MO110201/DI 69     2011